Nonathymulin in rheumatoid arthritis: two double blind, placebo controlled trials.
Two randomised double blind, placebo controlled trials have been carried out to assess the effectiveness of nonathymulin, a synthetic thymic peptide hormone, in the treatment of rheumatoid arthritis (RA) and to compare three different dosage schedules (1, 5, and 10 mg/day). Nonathymulin 5 mg proved...
Guardat en:
| Publicat a: | Ann Rheum Dis |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMJ Publishing Group
1987
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC1002191/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3310925/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/ard.46.7.549 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
